Latest Trials

Total 1472 results

Gruppo Oncologico Italiano di Ricerca Clinica

Unknown

Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLC

Advanced Non-Small Cell Lung Cancer

Italy
Tufts Medical Center
National Heart, Lung, and Blood Institute (NHLBI)

Completed

IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium. (IMMEDIATE)

Myocardial Infarction | Heart Diseases | Cardiovascular Diseases | Coronary Disease | Angina, Unstable | Heart Failure, Congestive

United States
vTv Therapeutics

Completed

Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial)

Embolism and Thrombosis | Hip Fractures | Venous Thromboembolism

Denmark, Czech Republic, Norway, Sweden
Ocular Therapeutix, Inc.

Completed

Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-CSI in Subjects With Dry Eye Disease.

Dry Eye Disease

United States
Angel Medical Systems

Recruiting

AngelMed Guardian® System PMA Post Approval Study

Acute Coronary Syndrome

United States
ETS Wound Care, LLC
Professional Education and Research Institute

Recruiting

Bioresorbable Glass Fiber Matrix in the Treatment of Diabetic Foot Ulcers (BGWM)

Diabetic Foot | Diabetic Foot Ulcer | Ulcer Foot

United States
AstraZeneca

Terminated

A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis of COVID-19 (ENDURE)

Coronavirus Disease 2019 (COVID-19)

United States
Sunovion

Completed

Study To Evaluate Patient Preference, Satisfaction And Efficacy Of a Nasal Aerosol Versus an Aqueous Nasal Spray

Perennial Allergic Rhinitis

United States
US Oncology Research
Fred Hutchinson Cancer Center; Chiron Corporation

Terminated

Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

United States
Hoffmann-La Roche

Completed

A Study to Evaluate Efficacy and Safety of Epoetin Beta (NeoRecormon®) in Anemic Participants With Breast Cancer Undergoing Chemotherapy

Anemia

Italy
Boehringer Ingelheim

Completed

Bi 671800 in Asthmatic Patients on Inhaled Corticosteroids

Asthma

United States
GlaxoSmithKline

Completed

Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)

Asthma

United States, Canada
Merck Sharp & Dohme LLC

Completed

Study of AzaSite Versus Vigamox Concentrations in the Conjunctiva and Aqueous Humor in Subjects Undergoing Routine Cataract Surgery

Bacterial Infections | Eye Infections | Cataract Extraction

United States
Pfizer
Sanofi

Completed

US Inhaled Insulin Dose Titration Study

Diabetes Mellitus, Type 2

United States
Akebia Therapeutics

Terminated

Study to Evaluate Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Who Are Hyporesponsive to Erythropoiesis Stimulating Agents

Anemia | Dialysis-Dependent Chronic Kidney Disease

United States
Celgene

Completed

ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer

Metastatic Breast Cancer

United States
Novartis Pharmaceuticals

Completed

Phase II Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide in Patients With Dumping Syndrome

Dumping Syndrome

Belgium, Netherlands, Germany, France, United States
Innocoll

Completed

Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty (MATRIX-1)

Pain, Postoperative

United States
Inhibrx, Inc.
Merck Sharp & Dohme LLC

Recruiting

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Melanoma | Renal Cell Carcinoma | Head and Neck Cancer | Gastric Cancer | Non-Small Cell Lung Cancer | Solid Tumor | Urothelial Carcinoma

United States
COUR Pharmaceutical Development Company, Inc.

Terminated

CNP-201 in Subjects With Peanut Allergy

Peanut Allergy

United States
Sanofi
BiPar Sciences

Completed

A Phase 2 Trial of Standard Chemotherapy, With or Without BSI-201, in Patients With Triple Negative Metastatic Breast Cancer

Breast Cancer

United States
Allergan

Completed

Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome

Arthritis, Rheumatoid | Lupus Erythematosus, Systemic | Scleroderma, Systemic | Keratoconjunctivitis Sicca | Sjogren's Syndrome

United States
Sanofi

Completed

Study of XL147 (SAR245408) or XL765 (SAR245409) in Combination With Letrozole in Subjects With Breast Cancer

Breast Cancer

United States, France, Spain
LivaNova

Terminated

Clinical Status Monitoring in Implantable Cardiac Defibrillator (ICD) Patients by Physiological Diagnosis (PhD) Function (TUTOR)

Heart Failure

Portugal, France, Italy, Belgium, Germany
Boehringer Ingelheim

Completed

Spiriva (Tiotropium Bromide) Assessment of FEV1 - (SAFE-Portugal).

Pulmonary Disease, Chronic Obstructive

Portugal
Celgene Corporation

Withdrawn

Study of Amrubicin With or Without Herceptin in Patients With Metastatic Breast Cancer

Metastatic Breast Cancer

United States
Pfizer

Completed

Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients

Venous Thromboembolism

United States, Norway, Russian Federation, Slovenia, Spain
GlaxoSmithKline

Completed

Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy.

Neoplasms, Breast

United States
AstraZeneca

Terminated

Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLC

Non Small Cell Lung Carcinoma

Italy
QOL Medical, LLC

Recruiting

7-Day Trial of Sucraid for Alleviating CSID Symptoms in Subjects With Low, Moderate, and Normal Sucrase Levels

Congenital Sucrase-Isomaltase Deficiency | CSID | Sucrase Isomaltase Deficiency

United States
CalciMedica, Inc.

Completed

A Study of Auxora in Patients With Severe COVID-19 Pneumonia

Pneumonia

United States
Avinger, Inc.

Completed

Chronic Total Occlusion Crossing With the Ocelot System - CONNECT II (CONNECTII)

Total Atherosclerotic Occlusion of Femoral Artery

United States, Italy, Germany
Dey

Completed

A Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment in Patients With COPD

COPD

United States
Mount Sinai Hospital, Canada
The Hospital for Sick Children; Sunnybrook Health Sciences Centre; University... and other collaborators

Recruiting

Dopamine vs. Norepinephrine for Hypotension in Very Preterm Infants With Late-onset Sepsis

Late-Onset Neonatal Sepsis | Neonatal Hypotension | Extreme Prematurity

Canada, United States, Ireland, Israel
Baxter Healthcare Corporation

Completed

Theranova 400 Dialyzer In End Stage Renal Disease (ESRD) Patients

End Stage Renal Disease

United States
Hoffmann-La Roche

Completed

OBELIX Study: A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Cancer of the Colon or Rectum.

Colorectal Cancer

Italy
Novartis Pharmaceuticals

Completed

Safety, Tolerability and Efficacy of Nidufexor in Patients With Diabetic Nephropathy

Diabetic Nephropathy

Czechia, Lebanon, United States, Argentina, Germany, Jordan, Turkey
TearClear Corp

Active, not recruiting

Prospective, Double-masked, Randomized, Multi-center, Active-controlled, Parallel-group, 3-month Study Assessing the Safety & Ocular Hypotensive Efficacy of TC-002 Ophthalmic Solution Compared to Latanoprost Ophthalmic Solution 0.005% in Subjects With Elevated Intraocular Pressure (TC-002-301)

Elevated Intraocular Pressure

United States
Aerie Pharmaceuticals

Completed

Rocklatan® Evaluation

Glaucoma

United States
Alcon Research

Terminated

Post Approval Study of the CyPass System

Cataract | Primary Open-angle Glaucoma

United States
Duke University
Amgen

Completed

Predischarge Initiation of Ivabradine in the Management of Heart Failure (PRIME-HF) (PRIME-HF)

Heart Failure

United States
Novartis Pharmaceuticals

Completed

Bronchodilator Effects and Safety of Glycopyrronium Bromide (25 ug and 50 ug o.d.) in Asthma

Asthma

Germany, United States, Belgium, Latvia, Lithuania, Japan
NYU Langone Health
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaborators

Completed

Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial (FONTII)

Focal Segmental Glomerulosclerosis

United States, Canada
Bausch Health Americas, Inc.

Active, not recruiting

Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative Colitis

Ulcerative Colitis

United States
Aerie Pharmaceuticals

Completed

AR-12286 in Combination With Latanoprost

Ocular Hypertension | Glaucoma

United States
Helixmith Co., Ltd.

Terminated

Safety and Efficacy Study of Engensis (VM202) in the Treatment of Chronic Non-Healing Foot Ulcers

Foot Ulcer, Diabetic

United States
Gruppo Oncologico del Nord-Ovest

Completed

FOLFOXIRI Compared With FOLFIRI for Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

Italy
Bristol-Myers Squibb

Completed

Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor

Advanced Breast Cancer

United States
Hoffmann-La Roche

Completed

THOR Study: A Study of Continued Herceptin (Trastuzumab) in Combination With Second Line Chemotherapy in Patients With HER2 Positive Metastatic Breast Cancer.

Breast Cancer

Italy
GlaxoSmithKline

Terminated

Randomized Discontinuation Study of Lapatinib Versus Placebo in Subjects With Documented Tumor Progression After Chemotherapy, or Where no Approved Therapy Exists

Cancer

United States

3

Subscribe